Scheherazade T Le, MD
Neurology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 18
- 4 carriers
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
18 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Le’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
18 of 18 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A101971 · Current
Licensed to practise in California · since 2007 · expires 2027-11-30 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$75,258
Medicare paid this office $75,258 for 216 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 51 | $26,399 | $29 |
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 45 | $16,679 | $183 |
| Long return visit (40+ min) | 23 | $5,061 | $141 |
| Placement of skin electrodes and measurement of central motor stimulation in arms and legs | 40 | $4,304 | $108 |
| Long return visit (40+ min) | 22 | $2,741 | $114 |
See all 13 services
| Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 51 | $26,399 | $29 |
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 45 | $16,679 | $183 |
| Long return visit (40+ min) | 23 | $5,061 | $141 |
| Placement of skin electrodes and measurement of central motor stimulation in arms and legs | 40 | $4,304 | $108 |
| Long return visit (40+ min) | 22 | $2,741 | $114 |
| New patient visit (60+ min) | 16 | $2,449 | $153 |
| Muscle electrical test | 32 | $2,361 | $74 |
| Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | 17 | $2,187 | $115 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs | 42 | $1,732 | $41 |
| Measurement of brain wave activity (eeg), in coma or asleep | 15 | $779 | $52 |
| Measurement of brain wave activity (eeg), awake and asleep | 14 | $570 | $41 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 34 | $524 | $15 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 27 | $479 | $14 |
Who their Medicare patients are
216 Original Medicare patients in 2024. Average age 66 · Under 65 30% · 85 and older 8% · Women 59% · Also on Medicaid 44% · Health risk score 1.76. Above the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 67% · Depression 35% · Stroke 29% · Chronic kidney disease 27% · Diabetes 26% · Coronary heart disease 23% · Dementia 22% · Atrial fibrillation 21% · Heart failure 19% · Cancer 15% · COPD 10%.
The office billed $772,621, Medicare allowed $98,057 and paid $75,258; for 1,459 services of 40 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 216 | 1,459 | 66 | 1.76 | $772,621 | $75,258 |
| 2023 | 247 | 1,483 | 67 | 1.76 | $1,175,918 | $78,885 |
| 2022 | 175 | 1,064 | 64 | 1.84 | $1,169,412 | $60,200 |
| 2021 | 217 | 1,471 | 66 | 1.74 | $1,411,813 | $76,754 |
| 2020 | 177 | 943 | 65 | 1.70 | $838,192 | $49,688 |
| 2019 | 228 | 983 | 66 | 1.69 | $562,009 | $74,326 |
| 2018 | 252 | 1,089 | 66 | 1.70 | $588,173 | $82,732 |
| 2017 | 261 | 1,112 | 66 | 1.64 | $562,805 | $71,742 |
| 2016 | 256 | 834 | 67 | 1.51 | $417,086 | $70,925 |
| 2015 | 156 | 485 | 66 | 1.52 | $245,202 | $51,008 |
| 2014 | 235 | 842 | 65 | 1.58 | $416,995 | $74,534 |
| 2013 | 212 | 912 | 66 | 1.74 | $341,099 | $71,437 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 54 | $25,228 | $30 |
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 46 | $13,887 | $190 |
| Long return visit (40+ min) | 42 | $7,802 | $118 |
| Placement of skin electrodes and measurement of central motor stimulation in arms and legs | 53 | $6,185 | $110 |
| Continuous monitoring of nervous system during operation, each 15 minutes | 12 | $4,657 | $30 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs | 53 | $2,365 | $42 |
| Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | 16 | $1,970 | $123 |
| New patient visit (60+ min) | 13 | $1,884 | $145 |
| Measurement of brain wave activity (eeg), in coma or asleep | 30 | $1,708 | $53 |
| Muscle electrical test | 17 | $1,366 | $76 |
| Measurement of brain wave activity (eeg), 2-12 hours with health care professional review and report | 13 | $1,309 | $94 |
| Short return visit (20+ min) | 14 | $732 | $52 |
| Return visit (30+ min) | 13 | $728 | $56 |
2022: 10 services
| Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 42 | $20,729 | $30 |
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 40 | $14,145 | $191 |
| Long return visit (40+ min) | 35 | $4,967 | $116 |
| Placement of skin electrodes and measurement of central motor stimulation in arms and legs | 36 | $4,152 | $112 |
| New patient visit (60+ min) | 13 | $1,963 | $151 |
| Return visit (30+ min) | 19 | $1,720 | $86 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs | 37 | $1,636 | $43 |
| Muscle electrical test | 16 | $1,233 | $77 |
| Measurement of brain wave activity (eeg), in coma or asleep | 19 | $1,081 | $54 |
| Short return visit (20+ min) | 13 | $676 | $48 |
2021: 9 services
| Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 61 | $32,077 | $31 |
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 42 | $13,747 | $194 |
| Placement of skin electrodes and measurement of central motor stimulation in arms and legs | 53 | $6,045 | $114 |
| Long return visit (40+ min) | 39 | $5,541 | $109 |
| Muscle electrical test | 30 | $2,351 | $78 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs | 51 | $2,236 | $44 |
| New patient visit (60+ min) | 13 | $1,907 | $147 |
| Return visit (30+ min) | 19 | $1,478 | $74 |
| Measurement of brain wave activity (eeg), in coma or asleep | 23 | $1,266 | $55 |
2020: 8 services
| Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 37 | $18,706 | $31 |
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 30 | $9,224 | $196 |
| Placement of skin electrodes and measurement of central motor stimulation in arms and legs | 37 | $4,364 | $115 |
| Return visit (30+ min) | 44 | $3,122 | $61 |
| Long return visit (40+ min) | 25 | $2,310 | $86 |
| Muscle electrical test | 20 | $1,580 | $79 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs | 34 | $1,545 | $44 |
| Measurement of brain wave activity (eeg), in coma or asleep | 16 | $945 | $56 |
2019: 10 services
| Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG) | 45 | $30,027 | $297 |
| Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 41 | $15,901 | $30 |
| Long return visit (40+ min) | 59 | $5,764 | $90 |
| Placement of skin electrodes and measurement of central motor stimulation in arms and legs | 38 | $4,254 | $112 |
| New patient visit (60+ min) | 14 | $2,090 | $149 |
| Return visit (30+ min) | 32 | $2,081 | $65 |
| Muscle electrical test | 26 | $2,006 | $77 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs | 35 | $1,511 | $43 |
| Measurement of brain wave activity (eeg), awake and asleep | 14 | $743 | $53 |
| Measurement of brain wave activity (eeg), in coma or asleep | 12 | $653 | $54 |
2018: 10 services
| Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG) | 50 | $33,999 | $293 |
| Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 39 | $16,629 | $30 |
| Long return visit (40+ min) | 62 | $6,438 | $84 |
| Placement of skin electrodes and measurement of central motor stimulation in arms and legs | 38 | $4,298 | $110 |
| Return visit (30+ min) | 34 | $2,049 | $54 |
| New patient visit (60+ min) | 12 | $1,663 | $139 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs | 34 | $1,488 | $43 |
| Muscle electrical test | 17 | $1,367 | $76 |
| Long return visit (40+ min) | 13 | $1,197 | $92 |
| Measurement of brain wave activity (eeg), in coma or asleep | 14 | $744 | $53 |
2017: 12 services
| Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG) | 39 | $19,058 | $293 |
| Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 46 | $16,307 | $30 |
| Long return visit (40+ min) | 67 | $7,853 | $86 |
| Placement of skin electrodes and measurement of central motor stimulation in arms and legs | 45 | $5,061 | $110 |
| New patient visit (60+ min) | 33 | $4,776 | $145 |
| Return visit (30+ min) | 54 | $3,385 | $55 |
| Continuous monitoring of nervous system during operation, each 15 minutes | 14 | $1,920 | $30 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs | 42 | $1,824 | $42 |
| Muscle electrical test | 24 | $1,820 | $76 |
| Measurement of brain wave activity (eeg), in coma or asleep | 13 | $743 | $53 |
| Measurement of brain wave activity (eeg), awake and asleep | 13 | $690 | $53 |
| Measurement of brain wave activity (eeg), awake and drowsy | 12 | $632 | $53 |
2016: 9 services
| Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG) | 51 | $29,190 | $292 |
| Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 23 | $9,527 | $29 |
| Long return visit (40+ min) | 63 | $6,706 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $4,259 | $93 |
| Return visit (30+ min) | 59 | $3,872 | $61 |
| New patient visit (60+ min) | 22 | $3,164 | $144 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,163 | $180 |
| Placement of skin electrodes and measurement of central motor stimulation in arms and legs | 17 | $1,860 | $109 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs | 17 | $713 | $42 |
2015: 4 services
| Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG) | 28 | $25,933 | $295 |
| Long return visit (40+ min) | 53 | $5,975 | $84 |
| New patient visit (60+ min) | 29 | $3,980 | $137 |
| Return visit (30+ min) | 17 | $1,054 | $59 |
2014: 11 services
| Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG) | 42 | $28,163 | $293 |
| Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 23 | $9,022 | $29 |
| Long return visit (40+ min) | 58 | $6,735 | $90 |
| New patient visit (60+ min) | 42 | $6,076 | $145 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $5,453 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,856 | $180 |
| Return visit (30+ min) | 31 | $1,960 | $58 |
| Placement of skin electrodes and measurement of central motor stimulation in arms and legs | 15 | $1,636 | $109 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,255 | $97 |
| Measurement of brain wave activity (eeg), awake and drowsy | 19 | $995 | $52 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs | 15 | $626 | $42 |
2013: 11 services
| Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG) | 52 | $30,183 | $285 |
| Continuous monitoring of nervous system during operation, each 15 minutes | 19 | $8,896 | $29 |
| New patient visit (60+ min) | 47 | $6,040 | $129 |
| Long return visit (40+ min) | 50 | $5,460 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $4,221 | $90 |
| Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 14 | $4,128 | $23 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,976 | $175 |
| Return visit (30+ min) | 29 | $2,163 | $64 |
| Placement of skin electrodes and measurement of central motor stimulation in arms and legs | 13 | $1,374 | $106 |
| Muscle electrical test | 12 | $883 | $74 |
| Short return visit | 12 | $216 | $17 |
Medicaid work
$3,869 in 2024
Medicaid paid $3,869 for 30 billed services this clinician did in 2024, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpretation and report after each 24-hour period; with video (VEEG) | 30 | $3,869 |
| 2024 | 30 | 1 | 16 | $3,869 |
| 2023 | 105 | 2 | 17 | $14,261 |
| 2022 | 16 | 1 | 16 | $642 |
| 2020 | 12 | 1 | 12 | $380 |
| 2018 | 26 | 1 | 13 | $964 |
See the largest Medicaid services in earlier years
2023
| Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpretation and report after each 24-hour period; with video (VEEG) | 80 | $13,455 |
| Long return visit (40+ min) | 25 | $806 |
2022
| Long return visit (40+ min) | 16 | $642 |
2020
| Return visit (30+ min) | 12 | $380 |
2018
| Long return visit (40+ min) | 26 | $964 |
Drugs they prescribed that Part D paid
$724,527
Pharmacies billed $724,527 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,264) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.
1,102 generic and 126 brand-name prescriptions · $724,527 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Epidiolex | 25 | $231,375 | $9,255 |
| Everolimus | 39 | $206,627 | $5,298 |
| Lacosamide | 192 | $35,708 | $186 |
| Aptiom | 11 | $28,516 | $2,592 |
| Nayzilam | 18 | $22,883 | $1,271 |
See all 26 drugs
| Epidiolex | 25 | $231,375 | $9,255 |
| Everolimus | 39 | $206,627 | $5,298 |
| Lacosamide | 192 | $35,708 | $186 |
| Aptiom | 11 | $28,516 | $2,592 |
| Nayzilam | 18 | $22,883 | $1,271 |
| Briviact | 12 | $16,965 | $1,414 |
| Diazepam | 20 | $16,895 | $845 |
| Fycompa | 13 | $15,201 | $1,169 |
| Clobazam | 55 | $14,301 | $260 |
| Rufinamide | 15 | $12,239 | $816 |
| Levetiracetam | 189 | $10,868 | $58 |
| Levetiracetam Er | 20 | $6,097 | $305 |
| Oxcarbazepine | 19 | $4,456 | $235 |
| Divalproex | 46 | $4,414 | $96 |
| Lamotrigine | 158 | $4,087 | $26 |
| Divalproex Sodium Er | 32 | $2,606 | $81 |
| Carbamazepine Er | 19 | $2,575 | $136 |
| Gabapentin | 49 | $1,732 | $35 |
| Pregabalin | 11 | $1,544 | $140 |
| Lamotrigine Er | 13 | $1,358 | $104 |
| Phenobarbital | 36 | $689 | $19 |
| Clonazepam | 67 | $540 | $8 |
| Risperidone | 15 | $457 | $30 |
| Zonisamide | 15 | $361 | $24 |
| Topiramate | 24 | $320 | $13 |
| Lorazepam | 38 | $72 | $2 |
Year by year
| 2024 | 1,264 | 118 | 0% (0) | 10% | $724,527 |
| 2023 | 1,112 | 115 | 0% (0) | 11% | $890,307 |
| 2022 | 1,107 | 122 | 0% (0) | 19% | $905,478 |
| 2021 | 1,108 | 104 | 0% (0) | 23% | $819,649 |
| 2020 | 1,079 | 101 | 0% (0) | None | $714,749 |
| 2019 | 1,016 | 107 | 0% (0) | 19% | $566,280 |
| 2018 | 991 | 117 | 0% (0) | None | $527,664 |
| 2017 | 873 | 121 | 0% (0) | 21% | $408,402 |
| 2016 | 626 | 99 | 0% (0) | 15% | $210,338 |
| 2015 | 519 | 83 | 0% (0) | None | $232,740 |
| 2014 | 513 | 81 | 0% (0) | 16% | $169,902 |
| 2013 | 326 | 64 | None | 11% | $20,826 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 26 drugs
| Everolimus | 29 | $295,349 | $10,184 |
| Epidiolex | 19 | $254,637 | $13,402 |
| Lacosamide | 151 | $101,002 | $669 |
| Nayzilam | 19 | $20,868 | $1,098 |
| Clobazam | 48 | $19,793 | $412 |
| Vimpat | 12 | $18,631 | $1,553 |
| Briviact | 12 | $17,823 | $1,485 |
| Fycompa | 13 | $15,000 | $1,154 |
| Levetiracetam | 161 | $13,004 | $81 |
| Diazepam | 11 | $8,583 | $780 |
| Tegretol | 13 | $7,091 | $545 |
| Lamotrigine | 134 | $6,588 | $49 |
| Carbamazepine Er | 29 | $6,215 | $214 |
| Olanzapine | 11 | $4,720 | $429 |
| Lamotrigine Er | 12 | $3,246 | $271 |
| Divalproex | 57 | $3,025 | $53 |
| Clorazepate Dipotassium | 12 | $2,008 | $167 |
| Gabapentin | 42 | $1,971 | $47 |
| Divalproex Sodium Er | 19 | $1,852 | $97 |
| Levetiracetam Er | 11 | $1,345 | $122 |
| Clonazepam | 56 | $1,119 | $20 |
| Risperidone | 12 | $909 | $76 |
| Zonisamide | 14 | $627 | $45 |
| Phenobarbital | 35 | $571 | $16 |
| Topiramate | 23 | $331 | $14 |
| Lorazepam | 43 | $217 | $5 |
2022: 26 drugs
| Afinitor | 18 | $323,479 | $17,971 |
| Epidiolex | 23 | $221,944 | $9,650 |
| Vimpat | 77 | $115,891 | $1,505 |
| Lacosamide | 74 | $44,784 | $605 |
| Clobazam | 51 | $24,545 | $481 |
| Xcopri | 17 | $21,839 | $1,285 |
| Fycompa | 17 | $20,160 | $1,186 |
| Briviact | 11 | $15,429 | $1,403 |
| Nayzilam | 11 | $12,576 | $1,143 |
| Levetiracetam | 150 | $12,231 | $82 |
| Divalproex | 66 | $12,109 | $183 |
| Felbamate | 17 | $11,586 | $682 |
| Olanzapine | 16 | $6,285 | $393 |
| Lamotrigine | 136 | $4,532 | $33 |
| Carbamazepine Er | 22 | $4,249 | $193 |
| Diazepam | 12 | $3,581 | $298 |
| Divalproex Sodium Er | 13 | $2,781 | $214 |
| Carbamazepine | 14 | $2,614 | $187 |
| Gabapentin | 44 | $2,376 | $54 |
| Oxcarbazepine | 12 | $1,722 | $144 |
| Phenobarbital | 31 | $744 | $24 |
| Zonisamide | 13 | $686 | $53 |
| Clonazepam | 60 | $422 | $7 |
| Risperidone | 20 | $312 | $16 |
| Topiramate | 19 | $178 | $9 |
| Lorazepam | 24 | $60 | $3 |
2021: 22 drugs
| Afinitor | 17 | $284,449 | $16,732 |
| Vimpat | 139 | $161,556 | $1,162 |
| Everolimus | 14 | $132,768 | $9,483 |
| Epidiolex | 25 | $90,706 | $3,628 |
| Fycompa | 18 | $30,919 | $1,718 |
| Aptiom | 12 | $16,294 | $1,358 |
| Clobazam | 58 | $14,291 | $246 |
| Levetiracetam | 161 | $13,022 | $81 |
| Divalproex | 83 | $8,574 | $103 |
| Divalproex Sodium Er | 30 | $5,373 | $179 |
| Carbamazepine Er | 21 | $3,980 | $190 |
| Lamotrigine | 140 | $3,214 | $23 |
| Carbamazepine | 20 | $2,965 | $148 |
| Gabapentin | 29 | $2,130 | $73 |
| Lamotrigine Er | 11 | $1,473 | $134 |
| Phenobarbital | 22 | $950 | $43 |
| Clonazepam | 59 | $588 | $10 |
| Zonisamide | 16 | $518 | $32 |
| Risperidone | 16 | $246 | $15 |
| Lorazepam | 47 | $208 | $4 |
| Citalopram Hbr | 12 | $133 | $11 |
| Sumatriptan | 21 | $132 | $6 |
2020: 22 drugs
| Afinitor | 16 | $281,453 | $17,591 |
| Vimpat | 114 | $131,372 | $1,152 |
| Aptiom | 20 | $66,281 | $3,314 |
| Epidiolex | 11 | $27,240 | $2,476 |
| Fycompa | 21 | $26,479 | $1,261 |
| Briviact | 12 | $15,466 | $1,289 |
| Levetiracetam | 201 | $12,255 | $61 |
| Divalproex | 75 | $9,091 | $121 |
| Clobazam | 27 | $6,983 | $259 |
| Lamotrigine Er | 12 | $4,401 | $367 |
| Lamotrigine | 140 | $4,206 | $30 |
| Carbamazepine Er | 19 | $3,788 | $199 |
| Pregabalin | 17 | $2,803 | $165 |
| Divalproex Sodium Er | 31 | $2,740 | $88 |
| Carbamazepine | 15 | $2,691 | $179 |
| Gabapentin | 37 | $2,596 | $70 |
| Zonisamide | 21 | $1,174 | $56 |
| Clorazepate Dipotassium | 13 | $784 | $60 |
| Clonazepam | 57 | $424 | $7 |
| Sumatriptan | 15 | $243 | $16 |
| Lorazepam | 38 | $142 | $4 |
| Citalopram Hbr | 16 | $60 | $4 |
2019: 23 drugs
| Afinitor | 18 | $293,697 | $16,316 |
| Vimpat | 91 | $96,648 | $1,062 |
| Aptiom | 17 | $65,813 | $3,871 |
| Briviact | 11 | $23,273 | $2,116 |
| Fycompa | 19 | $18,607 | $979 |
| Lyrica | 12 | $9,750 | $812 |
| Levetiracetam | 175 | $9,044 | $52 |
| Felbamate | 22 | $8,535 | $388 |
| Carbamazepine Er | 36 | $6,989 | $194 |
| Clobazam | 26 | $5,258 | $202 |
| Lamotrigine Er | 13 | $4,449 | $342 |
| Lamotrigine | 146 | $4,094 | $28 |
| Divalproex | 39 | $3,184 | $82 |
| Carbamazepine | 22 | $3,085 | $140 |
| Zonisamide | 39 | $1,443 | $37 |
| Gabapentin | 49 | $1,265 | $26 |
| Divalproex Sodium Er | 18 | $883 | $49 |
| Propranolol | 23 | $541 | $24 |
| Topiramate | 18 | $437 | $24 |
| Phenobarbital | 12 | $357 | $30 |
| Clonazepam | 41 | $312 | $8 |
| Donepezil | 14 | $264 | $19 |
| Lorazepam | 37 | $144 | $4 |
2018: 22 drugs
| Afinitor | 15 | $229,030 | $15,269 |
| Vimpat | 92 | $104,034 | $1,131 |
| Aptiom | 14 | $40,165 | $2,869 |
| Briviact | 21 | $36,100 | $1,719 |
| Onfi | 29 | $30,633 | $1,056 |
| Levetiracetam | 195 | $12,445 | $64 |
| Lyrica | 11 | $11,077 | $1,007 |
| Lamotrigine Er | 23 | $8,723 | $379 |
| Felbamate | 23 | $8,039 | $350 |
| Carbamazepine Er | 20 | $5,346 | $267 |
| Divalproex | 49 | $4,778 | $98 |
| Carbamazepine | 30 | $2,029 | $68 |
| Lamotrigine | 107 | $1,724 | $16 |
| Divalproex Sodium Er | 23 | $1,629 | $71 |
| Gabapentin | 74 | $1,452 | $20 |
| Zonisamide | 37 | $1,247 | $34 |
| Oxcarbazepine | 17 | $882 | $52 |
| Clonazepam | 31 | $207 | $7 |
| Topiramate | 12 | $192 | $16 |
| Lorazepam | 40 | $184 | $5 |
| Sumatriptan | 12 | $166 | $14 |
| Carbidopa-Levodopa | 11 | $155 | $14 |
2017: 23 drugs
| Afinitor | 13 | $171,241 | $13,172 |
| Vimpat | 64 | $56,094 | $876 |
| Onfi | 26 | $38,626 | $1,486 |
| Aptiom | 19 | $34,463 | $1,814 |
| Fycompa | 13 | $17,493 | $1,346 |
| Lyrica | 18 | $12,816 | $712 |
| Levetiracetam | 175 | $11,194 | $64 |
| Felbamate | 17 | $8,773 | $516 |
| Divalproex | 28 | $7,082 | $253 |
| Carbamazepine Er | 19 | $3,725 | $196 |
| Carbamazepine | 29 | $2,698 | $93 |
| Lamotrigine | 81 | $1,709 | $21 |
| Gabapentin | 91 | $1,629 | $18 |
| Levetiracetam Er | 21 | $1,533 | $73 |
| Divalproex Sodium Er | 15 | $1,222 | $81 |
| Desipramine | 12 | $1,082 | $90 |
| Phenobarbital | 12 | $908 | $76 |
| Zonisamide | 19 | $868 | $46 |
| Oxcarbazepine | 16 | $789 | $49 |
| Topiramate | 11 | $228 | $21 |
| Clonazepam | 28 | $218 | $8 |
| Escitalopram | 12 | $113 | $9 |
| Lorazepam | 14 | $53 | $4 |
2016: 19 drugs
| Vimpat | 32 | $34,977 | $1,093 |
| Aptiom | 14 | $29,250 | $2,089 |
| Onfi | 12 | $27,990 | $2,332 |
| Levetiracetam | 107 | $8,008 | $75 |
| Carbamazepine Er | 29 | $5,426 | $187 |
| Divalproex | 14 | $3,626 | $259 |
| Divalproex Sodium Er | 15 | $3,052 | $203 |
| Gabapentin | 83 | $1,906 | $23 |
| Carbamazepine | 14 | $1,850 | $132 |
| Lamotrigine | 65 | $1,303 | $20 |
| Dilantin | 11 | $1,053 | $96 |
| Zonisamide | 21 | $708 | $34 |
| Oxcarbazepine | 13 | $633 | $49 |
| Levetiracetam Er | 12 | $631 | $53 |
| Phenobarbital | 12 | $626 | $52 |
| Propranolol | 14 | $374 | $27 |
| Escitalopram | 14 | $106 | $8 |
| Clonazepam | 18 | $84 | $5 |
| Prednisone | 11 | $50 | $5 |
2015: 13 drugs
| Afinitor | 13 | $136,325 | $10,487 |
| Vimpat | 44 | $38,676 | $879 |
| Aptiom | 13 | $18,576 | $1,429 |
| Carbamazepine Er | 30 | $5,741 | $191 |
| Levetiracetam | 92 | $4,980 | $54 |
| Divalproex | 20 | $4,398 | $220 |
| Gabapentin | 64 | $1,683 | $26 |
| Lamotrigine | 46 | $874 | $19 |
| Zonisamide | 13 | $569 | $44 |
| Amitriptyline | 12 | $532 | $44 |
| Escitalopram | 17 | $301 | $18 |
| Topiramate | 14 | $188 | $13 |
| Clonazepam | 17 | $142 | $8 |
2014: 14 drugs
| Afinitor | 12 | $112,610 | $9,384 |
| Vimpat | 25 | $24,114 | $965 |
| Onfi | 12 | $8,498 | $708 |
| Levetiracetam | 104 | $5,097 | $49 |
| Carbamazepine | 18 | $2,788 | $155 |
| Tegretol | 12 | $1,676 | $140 |
| Lamotrigine | 66 | $1,582 | $24 |
| Gabapentin | 53 | $1,452 | $27 |
| Zonisamide | 14 | $1,388 | $99 |
| Divalproex | 13 | $1,206 | $93 |
| Topiramate | 28 | $438 | $16 |
| Amitriptyline | 11 | $184 | $17 |
| Baclofen | 12 | $143 | $12 |
| Lorazepam | 12 | $49 | $4 |
2013: 9 drugs
| Levetiracetam | 28 | $1,418 | $51 |
| Carbamazepine | 13 | $1,376 | $106 |
| Lamotrigine | 50 | $1,202 | $24 |
| Topiramate | 19 | $624 | $33 |
| Gabapentin | 25 | $620 | $25 |
| Zonisamide | 11 | $411 | $37 |
| Verapamil | 11 | $269 | $24 |
| Prednisone | 12 | $67 | $6 |
| Amitriptyline | 11 | $40 | $4 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1689857971
- Licence
- CA A101971California A101971: Current · expires 2027-11-30
- Trained
- University of California, San Francisco School of Medicine, 2006
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2084E0001X (2084E0001X); Neurology (2084N0400X); Federal specialty code 2084N0600X (2084N0600X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-12-11
- NPI last updated
- 2023-11-10
- NPI record certified
- 2023-11-10
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 725 Welch Rd, Palo Alto, CA, 94304